Key clinical studies for HIV coreceptor antagonists have used the phenotyping-based Trofile test. Meanwhile various simpler-to-do genotypic tests have become available that are compatible with standard laboratory equipment and Web-based interpretation tools. However, these systems typically analyze only the most prominent virus sequence in a specimen. We present a new diagnostic HIV tropism test not needing DNA sequencing. The system, XTrack, uses physical properties of DNA duplexes after hybridization of single-stranded HIV-1 env V3 loop probes to the clinical specimen. Resulting heteroduplexes possess unique properties driven by sequence relatedness to the reference and resulting in a discrete electrophoretic mobility. A detailed optimiza...
We developed a sequencing assay for genotypic HIV-1 tropism determination. The assay allows examinat...
the V3 loop is more sensitive than single PCR for detecting CXCR4-using viruses. Patients and method...
BACKGROUND:HIV-1 infected patients for whom standard gp160 phenotypic tropism testing failed are cur...
Key clinical studies for HIV coreceptor antagonists have used the phenotyping-based Trofile test. Me...
Key clinical studies for HIV coreceptor antagonists have used the phenotyping-based Trofile test. Me...
BACKGROUND: Trofile is the prospectively validated HIV-1 tropism assay. Its use is limited by high c...
BACKGROUND: Trofile is the prospectively validated HIV-1 tropism assay. Its use is limited by high ...
A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected individu...
HIV-1 coreceptor tropism assays are required to rule out the presence of CXCR4-tropic (non-R5) virus...
We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co-receptor us...
<div><p>A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected ...
We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co-receptor us...
BackgroundHIV-1 coreceptor tropism testing is used to evaluate eligibility for CCR5 antagonist thera...
International audienceThere have been few studies on the concordance between phenotypic assays for p...
CCR5 antagonists are a powerful new class of antiretroviral drugs that require a companion assay to ...
We developed a sequencing assay for genotypic HIV-1 tropism determination. The assay allows examinat...
the V3 loop is more sensitive than single PCR for detecting CXCR4-using viruses. Patients and method...
BACKGROUND:HIV-1 infected patients for whom standard gp160 phenotypic tropism testing failed are cur...
Key clinical studies for HIV coreceptor antagonists have used the phenotyping-based Trofile test. Me...
Key clinical studies for HIV coreceptor antagonists have used the phenotyping-based Trofile test. Me...
BACKGROUND: Trofile is the prospectively validated HIV-1 tropism assay. Its use is limited by high c...
BACKGROUND: Trofile is the prospectively validated HIV-1 tropism assay. Its use is limited by high ...
A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected individu...
HIV-1 coreceptor tropism assays are required to rule out the presence of CXCR4-tropic (non-R5) virus...
We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co-receptor us...
<div><p>A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected ...
We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co-receptor us...
BackgroundHIV-1 coreceptor tropism testing is used to evaluate eligibility for CCR5 antagonist thera...
International audienceThere have been few studies on the concordance between phenotypic assays for p...
CCR5 antagonists are a powerful new class of antiretroviral drugs that require a companion assay to ...
We developed a sequencing assay for genotypic HIV-1 tropism determination. The assay allows examinat...
the V3 loop is more sensitive than single PCR for detecting CXCR4-using viruses. Patients and method...
BACKGROUND:HIV-1 infected patients for whom standard gp160 phenotypic tropism testing failed are cur...